As part of #NCMentalHealthMonth, we sat down with Gabriel Vargas to discuss biomarkers and personalized medicine for mental health disorders.
As part of #NCMentalHealthMonth, Gabriel Vargas discusses the current state of the field and the potential for biomarkers and personalized medicine for mental health disorders.
Reid Alisch discusses the role of epigenetics in neuropsychiatric disorders, and how new epigenetic research could change future research and treatment practices.
In this #NCMentalHealthMonth interview, we speak to Miriam Greenberg and Wenxi Yu, who discuss the current hypotheses surrounding the therapeutic mechanisms of anti-bipolar drugs, as well as their hopes for the future of the field of bipolar disorder therapeutics.
Researchers from Vanderbilt University Medical Center (TN, USA) uncover the novel antipsychotic mechanism of muscarinic modulators.
We speak to Lance McCracken about his work in Acceptance and Commitment Therapy and his outlook for the future of behavioral therapies in pain management.
Researchers identify a distinct group of hypothalamic neurons implicated in anxiety that could be targeted in future treatments.
This brief overview evaluates the technical basis of new technologies within genomics, transcriptomics, proteomics, metabolomics and imaging and discusses how the extension of their clinical performance can lead to an objective diagnosis of MDD.